Citation Impact
Citing Papers
Visualizing enveloping layer glycans during zebrafish early embryogenesis
2010 StandoutNobel
The Metabolic Syndrome and Inflammation
2004
Electroencephalography.
1994
Inflammation and Type 2 Diabetes: Results from KORA Augsburg
2005
White blood-cell count and the risk of impaired fasting glucose or Type II diabetes in middle-aged Japanese men
2002
mTOR Signaling in Growth Control and Disease
2012 Standout
Inflammation and metabolic disorders
2006 StandoutNature
Five-Year Intra-Individual Variability in C-Reactive Protein Levels in a Japanese Population-Based Study
2000
Obesity, inflammation, and liver cancer
2011
Inflammation: the link between insulin resistance, obesity and diabetes
2003 Standout
Circulating levels of TNF-alpha and IL-6-relation to truncal fat mass and muscle mass in healthy elderly individuals and in patients with type-2 diabetes
2003
Interleukin-6 does/does not have a beneficial role in insulin sensitivity and glucose homeostasis
2006
Mechanisms linking obesity with cardiovascular disease
2006 StandoutNature
Sialic acids in human health and disease
2008
Obesity-induced gut microbial metabolite promotes liver cancer through senescence secretome
2013 StandoutNature
Regulation of mTOR function in response to hypoxia by REDD1 and the TSC1/TSC2 tumor suppressor complex
2004 StandoutNobel
The metabolic syndrome
2010 Standout
Regional differences of insulin action in adipose tissue: insights from in vivo and in vitro studies
2005
HIF2α cooperates with RAS to promote lung tumorigenesis in mice
2009 StandoutNobel
Adipocytes as regulators of energy balance and glucose homeostasis
2006 StandoutNature
Palmitate, but Not Unsaturated Fatty Acids, Induces the Expression of Interleukin-6 in Human Myotubes through Proteasome-dependent Activation of Nuclear Factor-κB
2004
Adipocyte differentiation induces dynamic changes in NF-κB expression and activity
2004
GPR120 Is an Omega-3 Fatty Acid Receptor Mediating Potent Anti-inflammatory and Insulin-Sensitizing Effects
2010 Standout
IKK-β links inflammation to obesity-induced insulin resistance
2005
Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance
2003 Standout
Is Type II diabetes mellitus a disease of the innate immune system?
1998
Type 2 diabetes as an inflammatory disease
2011 Standout
Circulating tumor necrosis factor alpha concentrations are higher in abdominal versus peripheral obesity
1999
Macrophage-specific PPARγ controls alternative activation and improves insulin resistance
2007 StandoutNature
Leukocyte Count, Erythrocyte Sedimentation Rate, and Diabetes Incidence in a National Sample of US Adults
2002
Interleukin-6 (IL-6) Induces Insulin Resistance in 3T3-L1 Adipocytes and Is, Like IL-8 and Tumor Necrosis Factor-α, Overexpressed in Human Fat Cells from Insulin-resistant Subjects
2003
The metabolic syndrome
2005 Standout
Induction of proinflammatory cytokines by long-chain saturated fatty acids in human macrophages
2008
TSC2 regulates VEGF through mTOR-dependent and -independent pathways
2003 StandoutNobel
Interleukin‐6 production in human subcutaneous abdominal adipose tissue: the effect of exercise
2002
The Role of Insulin Resistance in the Pathogenesis of Alzheimer??s Disease
2003
Diet–microbiota interactions as moderators of human metabolism
2016 StandoutNature
Stretch-induced Retinal Vascular Endothelial Growth Factor Expression Is Mediated by Phosphatidylinositol 3-Kinase and Protein Kinase C (PKC)-ζ but Not by Stretch-induced ERK1/2, Akt, Ras, or Classical/Novel PKC Pathways
2002
Functional interactions between the gut microbiota and host metabolism
2012 StandoutNature
Usefulness of a Highly Sensitive Urinary and Serum IL-6 Assay in Patients with Diabetic Nephropathy
2000
Lipopolysaccharide activates an innate immune system response in human adipose tissue in obesity and type 2 diabetes
2006
Complex chronic comorbidities of COPD
2007
Muscle‐derived interleukin‐6: possible biological effects
2001
C-Reactive Protein and Other Circulating Markers of Inflammation in the Prediction of Coronary Heart Disease
2004 Standout
Searching for the exercise factor: is IL-6 a candidate?
2003
Brown adipose tissue thermogenic adaptation requires Nrf1-mediated proteasomal activity
2018 StandoutNobel
Mechanisms linking obesity to insulin resistance and type 2 diabetes
2006 StandoutNature
Endocrine Regulation of Energy Metabolism by the Skeleton
2007 Standout
Influence of TNF-α and IL-6 infusions on insulin sensitivity and expression of IL-18 in humans
2006
Markers of inflammation and prediction of diabetes mellitus in adults (Atherosclerosis Risk in Communities study): a cohort study
1999
Elevated C-Reactive Protein Levels in Overweight and Obese Adults
1999 Standout
Paclitaxel plus Bevacizumab versus Paclitaxel Alone for Metastatic Breast Cancer
2007 Standout
Inflammatory Markers and Loss of Muscle Mass (Sarcopenia) and Strength
2006
The accelerator hypothesis: weight gain as the missing link between Type I and Type II diabetes
2001
Association between Physical Activity and Markers of Inflammation in a Healthy Elderly Population
2001
The Inflammasomes
2010 Standout
Albuminuria and Risk of Cardiovascular Events, Death, and Heart Failure in Diabetic and Nondiabetic Individuals
2001 Standout
Obesity, Inflammation, and Insulin Resistance
2007
Suppressors of Cytokine Signaling-1 and -6 Associate with and Inhibit the Insulin Receptor
2001
What We Talk About When We Talk About Fat
2014 Standout
IL-6 enhances plasma IL-1ra, IL-10, and cortisol in humans
2003
Interleukin-6 and tumor necrosis factor-? are not increased in patients with Type 2 diabetes: evidence that plasma interleukin-6 is related to fat mass and not insulin responsiveness
2004
Macrophage biology in development, homeostasis and disease
2013 StandoutNature
C‐reactive protein, its role in inflammation, Type 2 diabetes and cardiovascular disease, and the effects of insulin‐sensitizing treatment with thiazolidinediones
2004
Insulin resistance in patients with rheumatoid arthritis: effect of anti‐TNFα therapy
2007
Inflammatory mediators and islet ?-cell failure: a link between type 1 and type 2 diabetes
2003
NLRP3 inflammasomes are required for atherogenesis and activated by cholesterol crystals
2010 StandoutNature
Inflammation, metaflammation and immunometabolic disorders
2017 StandoutNature
Gut flora metabolism of phosphatidylcholine promotes cardiovascular disease
2011 StandoutNature
Age and Duration of Follow-up as Modulators of the Risk for Ischemic Heart Disease Associated With High Plasma C-Reactive Protein Levels in Men
2001
Frailty in elderly people
2013 Standout
Angiogenesis as a therapeutic target
2005 StandoutNature
COVID-19 prevention and treatment: A critical analysis of chloroquine and hydroxychloroquine clinical pharmacology
2020
Pathways towards and away from Alzheimer's disease
2004 StandoutNature
Exercise normalises overexpression of TNF-α in knockout mice
2004
The Many Roles of Chemokines and Chemokine Receptors in Inflammation
2006 Standout
Repurposed Antiviral Drugs for Covid-19 — Interim WHO Solidarity Trial Results
2020 Standout
Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease
2012 Standout
Horror Autoinflammaticus: The Molecular Pathophysiology of Autoinflammatory Disease
2009
Diagnosis and Management of the Metabolic Syndrome
2005 Standout
Interleukin-1 Receptor Antagonist Genotype Is Associated With Coronary Atherosclerosis in Patients With Type 2 Diabetes
2002
Inflammatory Cytokine Concentrations Are Acutely Increased by Hyperglycemia in Humans
2002 Standout
Muscle‐derived interleukin‐6: mechanisms for activation and possible biological roles
2002
Differential Effects of Interleukin-6 and -10 on Skeletal Muscle and Liver Insulin Action In Vivo
2004
Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance
2003 Standout
Promoter Polymorphisms of the TNF-α (G-308A) and IL-6 (C-174G) Genes Predict the Conversion From Impaired Glucose Tolerance to Type 2 Diabetes
2003
A Transgenic Model of Visceral Obesity and the Metabolic Syndrome
2001 StandoutScience
von Willebrand Factor, C-Reactive Protein, and 5-Year Mortality in Diabetic and Nondiabetic Subjects
1999
Intensive Diabetes Treatment and Cardiovascular Disease in Patients with Type 1 Diabetes
2005 Standout
High White Blood Cell Count Is Associated With a Worsening of Insulin Sensitivity and Predicts the Development of Type 2 Diabetes
2002
Vascular Permeability Factor/Vascular Endothelial Growth Factor: A Critical Cytokine in Tumor Angiogenesis and a Potential Target for Diagnosis and Therapy
2002
Reversal of Obesity- and Diet-Induced Insulin Resistance with Salicylates or Targeted Disruption of Ikkβ
2001 StandoutScience
Infectious Agents Are Not Necessary for Murine Atherogenesis
2000
Insulin Resistance and Chronic Cardiovascular Inflammatory Syndrome
2003
Islet Inflammation Impairs the Pancreatic β-Cell in Type 2 Diabetes
2009
Chronic Subclinical Inflammation as Part of the Insulin Resistance Syndrome
2000 Standout
pVHL suppresses kinase activity of Akt in a proline-hydroxylation–dependent manner
2016 StandoutScienceNobel
C-Reactive Protein Increases Plasminogen Activator Inhibitor-1 Expression and Activity in Human Aortic Endothelial Cells
2003
Inflammatory Markers and Risk of Developing Type 2 Diabetes in Women
2004
Normalization of Tumor Vasculature: An Emerging Concept in Antiangiogenic Therapy
2005 StandoutScience
Functional connectivity in the resting brain: A network analysis of the default mode hypothesis
2002 Standout
Regulation of Adaptive Immunity by the Innate Immune System
2010 StandoutScience
The adipocyte: a model for integration of endocrine and metabolic signaling in energy metabolism regulation
2001
The Relation of Markers of Inflammation to the Development of Glucose Disorders in the Elderly
2001
Association between C-reactive protein and features of the metabolic syndrome: a population-based study.
2000
C-Reactive Protein, Interleukin 6, and Risk of Developing Type 2 Diabetes Mellitus
2001 Standout
Interleukin-6 gene polymorphism and insulin sensitivity.
2000
Exercise and IL‐6 infusion inhibit endotoxin‐induced TNF‐α production in humans
2003
The anti-inflammatory effect of exercise
2005 Standout
Obesity-Related Upregulation of Monocyte Chemotactic Factors in Adipocytes
2008
The effect of intensive diabetes therapy on measures of autonomic nervous system function in the Diabetes Control and Complications Trial (DCCT)
1998
Chemical Glycoproteomics
2016 StandoutNobel
Inflammatory Cytokines and the Risk to Develop Type 2 Diabetes
2003
Works of Gary Chusney being referenced
Plasma sialic acid in animal models of diabetes mellitus: Evidence for modulation of sialic acid concentrations by insulin deficiency
1995
The innate immune response and type 2 diabetes: evidence that leptin is associated with a stress‐related (acute‐phase) reaction
2000
Plasma interleukin-6, tumour necrosis factor α and blood cytokine production in type 2 diabetes
2000
Serum Sialic Acid Concentration and Coronary Heart Disease in NIDDM
1995
NIDDM as a disease of the innate immune system: association of acute-phase reactants and interleukin-6 with metabolic syndrome X
1997
Effect of Antecedent Glucose Control on Cerebral Function During Hypoglycemia
1991
Hydroxycloroquine blood concentration in lupus nephritis: a determinant of disease outcome?
2017
Mechanical stretch induces vascular permeability factor in human mesangial cells: Mechanisms of signal transduction
1997